The University of Warwick Library - WebBridge
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE) : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
James,
Nicholas D..
The Lancet.
v.
387.
no.
10024.
2015-03-19.
p.
1163 -
1177...
issn:
0140-6736
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.